These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1937541)

  • 1. Immunological self-tolerance: an analysis employing cytokines or cytokine receptors encoded by transgenes or a recombinant vaccinia virus.
    Kroemer G; de Cid R; Moreno de Alborán I; Gonzalo JA; Iglesias A; Martínez C; Gutierrez-Ramos JC
    Immunol Rev; 1991 Aug; 122():173-204. PubMed ID: 1937541
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus.
    Gutierrez-Ramos JC; Andreu JL; Revilla Y; Viñuela E; Martinez C
    Nature; 1990 Jul; 346(6281):271-4. PubMed ID: 1973822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune dysfunctions and activation of natural killer cells in human IL-2 and IL-2/IL-2 receptor L-chain transgenic mice.
    Ishida Y; Nishi M; Taguchi O; Inaba K; Minato N; Kawaichi M; Honjo T
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():695-704. PubMed ID: 2640624
    [No Abstract]   [Full Text] [Related]  

  • 5. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
    Aarts WM; Schlom J; Hodge JW
    Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution.
    Jackaman C; Nelson DJ
    Cancer Gene Ther; 2010 Jun; 17(6):429-40. PubMed ID: 20150930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice.
    Ishida Y; Nishi M; Taguchi O; Inaba K; Hattori M; Minato N; Kawaichi M; Honjo T
    J Exp Med; 1989 Oct; 170(4):1103-15. PubMed ID: 2571665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of autoimmune disease by the E3 ubiquitin ligase Itch.
    Moser EK; Oliver PM
    Cell Immunol; 2019 Jun; 340():103916. PubMed ID: 31126634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2, autotolerance, and autoimmunity.
    Kroemer G; Andreu JL; Gonzalo JA; Gutierrez-Ramos JC; Martínez C
    Adv Immunol; 1991; 50():147-235. PubMed ID: 1950796
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy.
    Chen B; Timiryasova TM; Gridley DS; Andres ML; Dutta-Roy R; Fodor I
    Cytokine; 2001 Sep; 15(6):305-14. PubMed ID: 11594797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2, Interleukin-7, T cell-mediated autoimmunity, and N-glycosylation.
    Grigorian A; Mkhikian H; Demetriou M
    Ann N Y Acad Sci; 2012 Apr; 1253():49-57. PubMed ID: 22288682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of high-affinity IL-2-IL-2R interaction for T cell anergy induction.
    Hayashi RJ; Kanagawa O
    Int Immunol; 2006 May; 18(5):645-51. PubMed ID: 16574670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell receptor transgenic mice in the study of autoimmune diseases.
    Lafaille JJ
    J Autoimmun; 2004 Mar; 22(2):95-106. PubMed ID: 14987736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and autoimmunity.
    O'Shea JJ; Ma A; Lipsky P
    Nat Rev Immunol; 2002 Jan; 2(1):37-45. PubMed ID: 11905836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mouse immune response to human fibrinogen reveals an autoimmune component against mouse fibrinogen.
    Rubin B; Matron C
    Cell Immunol; 2005 Jan; 233(1):41-52. PubMed ID: 15876427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interleukin 2].
    Voĭtenok NN
    Ter Arkh; 1988; 60(5):42-6. PubMed ID: 3051488
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors.
    Malek TR; Porter BO; Codias EK; Scibelli P; Yu A
    J Immunol; 2000 Mar; 164(6):2905-14. PubMed ID: 10706676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.
    Sakaguchi S
    Nat Immunol; 2005 Apr; 6(4):345-52. PubMed ID: 15785760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic autoimmune disease as a consequence of defective lymphocyte death.
    Hünig T; Schimpl A
    Curr Opin Immunol; 1997 Dec; 9(6):826-30. PubMed ID: 9492985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coevolution of hosts and microorganisms: an analysis of the involvement of cytokines in host-parasite interactions.
    Williams O; Gonzalo JA; Martínez C; Kroemer G
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():11-21. PubMed ID: 1342705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.